Advances in endonasal low intensity laser irradiation therapy

Jian-Ling Jiao; Timon Cheng-Yi Liu; Jiang Liu; Li-Ping Cui; Song-hao Liu

doi:10.1117/12.639314

11 September 2006 Advances in endonasal low intensity laser irradiation therapy

Jian-Ling Jiao, Timon Cheng-Yi Liu, Jiang Liu, Li-Ping Cui, Song-hao Liu

Proceedings Volume 5967, 2004 Shanghai International Conference on Laser Medicine and Surgery; 59671C (2006) https://doi.org/10.1117/12.639314
Event: 2004 Shanghai international Conference on Laser Medicine and Surgery, 2004, Shanghai, China

Abstract

Endonasal low intensity laser therapy (ELILT) began in China in 1998. Now in China it is widely applied to treat hyperlipidemia and brain diseases such as Alzheimer's disease, Parkinson's disease, insomnia, poststroke depression, intractable headache, ache in head or face, cerebral thrombosis, acute ischemic cerebrovascular disease, migraine, brain lesion and mild cognitive impairment. There are four pathways mediating EILILT, Yangming channel, autonomic nervous systems and blood cells. Two unhealth acupoints of Yangming channal inside nose might mediate the one as is low intensity laser acupuncture. Unbalance autonomic nervous systems might be modulated. Blood cells might mediate the one as is intravascular low intensity laser therapy. These three pathways are integrated in ELILT so that serum amyloid β protein, malformation rate of erythrocyte, CCK-8, the level of viscosity at lower shear rates and hematocrit, or serum lipid might decrease, and melanin production, SOD activity or β endorphin might increase after ELILT treatment. These results indicate ELILT might work, but it need to be verified by randomized placebo-controlled trial.

Citation Download Citation

Jian-Ling Jiao, Timon Cheng-Yi Liu, Jiang Liu, Li-Ping Cui, and Song-hao Liu "Advances in endonasal low intensity laser irradiation therapy", Proc. SPIE 5967, 2004 Shanghai International Conference on Laser Medicine and Surgery, 59671C (11 September 2006); https://doi.org/10.1117/12.639314

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available